0000899243-18-024910.txt : 20180920
0000899243-18-024910.hdr.sgml : 20180920
20180920162001
ACCESSION NUMBER: 0000899243-18-024910
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171002
FILED AS OF DATE: 20180920
DATE AS OF CHANGE: 20180920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rosen Oliver
CENTRAL INDEX KEY: 0001714870
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38219
FILM NUMBER: 181079667
MAIL ADDRESS:
STREET 1: C/O DECIPHERA PHARMACEUTICALS, LLC
STREET 2: 500 TOTTEN POND ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001654151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200299725
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 TOTTEN POND ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-209-6400
MAIL ADDRESS:
STREET 1: 500 TOTTEN POND ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20150928
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-10-02
0
0001654151
Deciphera Pharmaceuticals, Inc.
DCPH
0001714870
Rosen Oliver
C/O DECIPHERA PHARMACEUTICALS, INC.
500 TOTTEN POND ROAD
WALTHAM
MA
02451
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
1.89
2017-10-02
4
M
0
36746
D
2025-12-17
Common Stock
207614
0
D
Stock Option (Right to Buy)
1.89
2017-10-02
4
M
0
207614
A
2025-12-17
Common Stock
207614
207614
D
Stock Option (Right to Buy)
1.89
2017-10-02
4
M
0
8166
D
2025-12-17
Common Stock
46137
0
D
Stock Option (Right to Buy)
1.89
2017-10-02
4
M
0
46137
A
2025-12-17
Common Stock
46137
46137
D
Stock Option (Right to Buy)
3.95
2017-10-02
4
M
0
8500
D
2026-09-26
Common Stock
48025
0
D
Stock Option (Right to Buy)
3.95
2017-10-02
4
M
0
48025
A
2026-09-26
Common Stock
48025
48025
D
Stock Option (Right to Buy)
6.13
2017-10-02
4
M
0
8121
D
2027-06-03
Common Stock
45883
0
D
Stock Option (Right to Buy)
6.13
2017-10-02
4
M
0
45883
A
2027-06-03
Common Stock
45883
45883
D
Stock Option (Right to Buy)
29.71
2018-02-16
4
A
0
68500
0.00
A
2028-02-15
Common Stock
68500
68500
D
Immediately prior to the closing of the Issuer's initial public offering, these options to purchase common stock of Deciphera Pharmaceuticals, LLC were exchanged for options to purchase common stock of the Issuer on a 1 for 5.65 basis pursuant to that certain Reorganization Agreement and Plan of Merger by and among the Issuer, Deciphera Pharmaceuticals, LLC and the other parties named therein, dated September 26, 2017 (the "Merger Agreement"). These transactions were exempt from Section 16(b) in reliance upon Rule 16b-3 and Rule 16b-6(b).
This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option vests in 16 equal quarterly installments at the end of each quarter following the vesting commencement date of June 6, 2014, subject to continued service through such dates.
Represents the total number of options to purchase common stock of the Issuer received upon the exchange of options to purchase common stock of Deciphera Pharmaceuticals, Inc. for options to purchase common stock of the Issuer pursuant to the Merger Agreement.
This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option vests in 48 equal monthly installments at the end of each month following the vesting commencement date of September 30, 2015, subject to continued service through such dates.
This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option vests in 48 equal monthly installments at the end of each month following the vesting commencement date of July 1, 2016, subject to continued service through such dates.
This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option vests in 48 equal monthly installments at the end of each month following the vesting commencement date of May 26, 2017, subject to continued service through such dates.
This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option vests in 48 equal monthly installments following the vesting commencement date of January 1, 2018, subject to continued service through such dates.
/s/ Jeffrey M. Held, Attorney-in-Fact
2018-09-20